Retinal Therapy Study

Inside the report

1. 01 Coverage pathwayshow physician-administered ocular agents are reimbursed today
2. 02 Access in practicethe steps between prescription and treatment, and where patients drop out
3. 03 Clinical challengeswhat retina specialists say gets in the way of the treatment they want to give
4. 04 Payer requirementsprior authorisation, step therapy and documentation burden
5. 05 Treatment strategieshow coverage shapes agent choice and dosing intervals
6. 06 Recommendationswhat would ease access for patients and practices

What this report tells you

Reimbursement decides a great deal of what happens in retinal care. This report looks at the coverage and reimbursement pathways for physician-administered ocular agents, from the perspective of the specialists who prescribe and administer them.

It covers how coverage works in practice, the clinical challenges that follow from it, the payer requirements practices navigate, and how all of this shapes treatment strategy and patient access.

The full report is available on request. Leave your details below and our team will email it to you.